The treatment of psoriasis.
Rotstein
H
H
St Vincent's Hospital, Fitzroy, Vic.
Baker
C
C
D000284:Administration, Oral; D000287:Administration, Topical; D000875:Anthralin / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001510:Bed Rest; D002908:Chronic Disease; D003033:Coal Tar / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004643:Emollients; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D008466:Mechlorethamine / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010342:Patient Acceptance of Health Care; D010789:Phototherapy; D011565:Psoriasis / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D012176:Retinoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014467:Ultraviolet Therapy
D000893:Anti-Inflammatory Agents; D004643:Emollients; D005938:Glucocorticoids; D012176:Retinoids; D008466:Mechlorethamine; D003033:Coal Tar; D005472:Fluorouracil; D000875:Anthralin; D008727:Methotrexate